Bipolar disorder treatment for Deerfield Beach — the diagnosis primary care misses.

RECO Integrated Psychiatry is 13 miles north of Deerfield Beach — a 22-minute drive from The Cove or Hillsboro Beach up I-95 or A1A. The practice is built around mood-disorder specialty care: structured bipolar diagnosis using MDQ and HCL-32, lithium prescribing with full monitoring, and disciplined use of lamotrigine, quetiapine, lurasidone, and valproate rather than default SSRI trials. In-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS.

Deerfield Beach sits 13 miles south of RECO Integrated Psychiatry’s Delray Beach office — a 22-minute drive up A1A or I-95 that most clients from The Cove, Pioneer Park, Hillsboro Beach, Cresthaven, and Goldcoast Centre treat as part of their routine. For adults living with bipolar disorder, the drive is short enough to keep work and family intact and long enough to see a psychiatrist whose caseload is built around mood disorders rather than general behavioral health. The distinction matters because bipolar disorder — particularly bipolar II — is one of the most frequently missed diagnoses in primary care, and the cost of missing it is measured in years of failed antidepressant trials.

Bipolar I, bipolar II, and bipolar spectrum are three different treatment problems

Bipolar I is defined by at least one manic episode: seven days of elevated or irritable mood with grandiosity, decreased need for sleep, pressured speech, or reckless behavior severe enough to cause functional impairment or hospitalization. Bipolar II requires a hypomanic episode — four days of the same symptom cluster at a subthreshold intensity — plus at least one major depressive episode. Bipolar spectrum captures presentations that don’t cleanly meet criteria: cyclothymia, BP-NOS, antidepressant-induced hypomania, and subthreshold cyclicity with a strong family history. The distinction is not academic. It changes the pharmacology.

Bipolar I is generally treated with a mood stabilizer plus a second-generation antipsychotic. Bipolar II depression responds well to lamotrigine and quetiapine, less predictably to lithium monotherapy, and poorly to unopposed SSRIs. Bipolar spectrum presentations require careful antidepressant use with mood stabilizer cover and an honest conversation about what the diagnosis does and does not predict.

The evaluation at RECO uses the Mood Disorder Questionnaire (MDQ), the HCL-32, structured hypomania history from the client and — with consent — a family member, and prospective mood charting over the first several weeks. The PHQ-9 and GAD-7 track depression and anxiety alongside. A rushed 15-minute intake will not surface a bipolar II diagnosis; a structured evaluation usually will.

Lithium: the treatment we take seriously when others don’t

Lithium remains the most effective long-term mood stabilizer in bipolar disorder and the only psychiatric medication with robust anti-suicide evidence. For clients who tolerate it, the outcomes justify the monitoring. Baseline workup includes TSH, creatinine and eGFR, calcium, CBC, and a pregnancy test where relevant. Maintenance targets a serum level of 0.6-1.0 mEq/L drawn 12 hours post-dose, with levels checked weekly during titration, then quarterly, then twice yearly once stable.

Ongoing monitoring covers weight, thirst and polyuria, tremor, thyroid function every six months, and renal function annually. Lithium is not the right medication for every client — significant chronic kidney disease, unstable fluid balance, or an inability to attend labs are real contraindications — but the reflexive avoidance of lithium in favor of newer agents with weaker maintenance data is a pattern worth pushing against. Many clients arrive at RECO having never been offered lithium; a substantial minority end up on it.

Second-generation antipsychotics and where they fit

Quetiapine has FDA approval across bipolar depression, mania, and maintenance, which makes it one of the most versatile options in the class. Lurasidone is approved for bipolar depression with a favorable metabolic profile. Aripiprazole is used for mania and maintenance. Olanzapine and the olanzapine-fluoxetine combination are effective in bipolar depression and mania but carry the highest metabolic burden. Risperidone and cariprazine round out the mania and mixed-features options.

Selection is driven by the current phase, prior response history, tolerability, and the client’s baseline metabolic status. Standard monitoring — weight and waist circumference, fasting glucose or HbA1c, lipid panel, and blood pressure — happens at baseline, twelve weeks, and annually thereafter. Prolactin and EPS are checked clinically. RECO’s bipolar disorder treatment protocol pairs antipsychotic prescribing with the metabolic follow-up that too often gets skipped in general practice.

Lamotrigine, valproate, and the anticonvulsant options

Lamotrigine has the strongest maintenance evidence for bipolar disorder where depression is the predominant pole, and it is a first-line option for bipolar II depression. Titration is deliberately slow — 25 mg daily for two weeks, 50 mg for two weeks, 100 mg for one week, then 200 mg — because of Stevens-Johnson syndrome and DRESS risk. Any rash prompts immediate discontinuation and evaluation.

Valproate is effective for acute mania and mixed states, with target serum levels of 50-125 mcg/mL and monitoring of LFTs, platelets, and ammonia when clinically indicated. It is teratogenic and generally avoided in clients of reproductive age unless contraception is in place and the risks are documented. Carbamazepine is a second-line option with CBC and LFT monitoring plus attention to CYP450 interactions. Each of these anticonvulsants has a defined monitoring protocol; RECO’s practice runs each of them rather than defaulting to whichever the last prescriber chose.

What the first visit looks like

The initial evaluation is 60-90 minutes. A psychiatrist takes a full longitudinal history — mood episodes going back to adolescence, family psychiatric history, medication trials with dose and duration, substance use, medical comorbidities, and current stressors. Structured instruments (MDQ, HCL-32, PHQ-9, GAD-7, ASRS where ADHD is on the differential) are folded into the interview rather than handed out on a clipboard.

Baseline labs are ordered at the first visit — CBC, CMP, TSH, HbA1c, lipid panel, vitamin D, and any medication-specific labs (lithium level if already on lithium, valproate level if applicable). If the diagnosis is uncertain, prospective mood charting for two to four weeks often resolves it. A written treatment plan with medication rationale and monitoring schedule is shared at the end of the visit.

Insurance and getting to Delray Beach from Deerfield Beach

RECO Integrated Psychiatry is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS. Benefits are verified before the first appointment and the specific copay, deductible status, and any prior authorization requirements for TMS, Spravato, or specialty medications are communicated in writing. From Deerfield Beach, the drive is 13 miles and averages 22 minutes — north on I-95 to Atlantic Avenue, or up A1A along the coast if the appointment is midday. Telepsychiatry is available for stable follow-ups once the treatment relationship is established.

Serving residents of: The Cove, Pioneer Park, Hillsboro Beach, Cresthaven, Goldcoast Centre.